Gardasil Trial Termination Is More Good News For Merck

Data and safety monitoring board’s recommendation to switch placebo patients in FUTURE studies to the vaccine comes on the heels of an “approvable” letter for Novartis’ potential Januvia competitor Galvus.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet